Document is current
Any future updates will be listed below
-
Authors
Koppe, Uwe http://orcid.org/0000-0001-9718-5811
Schilling, Julia
Stecher, Melanie
Rüthrich, Maria Madeleine
Marquis, Adine
Diercke, Michaela
Haselberger, Martina
Koll, Carolin E. M.
Niebank, Michaela
Ruehe, Bettina
Borgmann, Stefan
Grabenhenrich, Linus
Hellwig, Kerstin
Pilgram, Lisa
Spinner, Christoph D.
Paerisch, Thomas
,
Spinner, Christoph D.
Rüthrich, Maria Madeleine
Lanznaster, Julia
Borgmann, Stefan
Hellwig, Kerstin
Vehreschild, Maria
Hohmann, Christian
Hanses, Frank
Wille, Kai
Jensen, Bjoern-Erik
Hower, Martin
Rieg, Siegbert
vom Dahl, Juergen
Rupp, Jan
Roemmele, Christoph
Isberner, Nora
Rothfuss, Katja
Eberwein, Lukas
Jung, Norma
Westhoff, Timm
Dolff, Sebastian
Strauss, Richard
Voigt, Ingo
von Bergwelt-Baildon, Michael
Merle, Uta
Degenhardt, Christian
Beutel, Gernot
Walter, Lorenz
Göpel, Siri
Gruener, Beate
Rauschning, Dominic
Trauth, Janina
Milovanovic, Milena
de With, Katja
Markart, Philipp
Rueddel, Jessica
Friedrichs, Anette
Kielstein, Jan
Tometten, Lukas
Heigener, David
Wojtecki, Lars
Schubert, Joerg
Guggemos, Wolfgang
Roeseler, Stefani
Neufang, Mark
-
Funding
Funding for this research was provided by:
Robert Koch-Institut
- License Information
-
More Information
Article History
Received: 31 August 2022
Accepted: 27 January 2023
First Online: 10 February 2023
Declarations
:
: Consent to participate for LEOSS was not required as data collection was anonymized and approved by the ethics committee of the Goethe University Frankfurt (department: medicine, No 20-600) as well as by local ethics committees, where applicable. LEOSS was registered at the German Clinical Trails Register (DRKS, No. S00021145). This study was conducted using data from the mandatory German COVID-19 surveillance system. Based on the Infectious Diseases Prevention Act (Infektionsschutzgesetz) the Robert Koch Institute is authorized and obliged to process, analyse and publish the respective surveillance data so that informed consent and ethical approval were not required. Data management was conducted according to GDPR principles and additional national data protection regulations. Within this manuscript only anonymized aggregated data are shown. All analyses were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: CDS reports grants, personal fees from AstraZeneca, personal fees and non-financial support from BBraun Melsungen, personal fees from BioNtech, grants, personal fees and non-financial support from Gilead Sciences, grants and personal fees from Janssen-Cilag, personal fees from Eli Lilly, personal fees from Formycon, personal fees from Roche, other from Apeiron, grants and personal fees from MSD, grants from Cepheid, personal fees from GSK, personal fees from Molecular partners, other from Eli Lilly, personal fees from SOBI during the conduct of the study; personal fees from AbbVie, personal fees from MSD, personal fees from Synairgen, grants and personal fees from ViiV Healthcare, outside the submitted work. The other authors report no conflict of interest.
